Gemina Laboratories Ltd. 8I7.F Stock
Gemina Laboratories Ltd. Price Chart
Gemina Laboratories Ltd. 8I7.F Financial and Trading Overview
| Gemina Laboratories Ltd. stock price | 0.29 EUR |
| Previous Close | 0.37 EUR |
| Open | 0.35 EUR |
| Bid | 0.35 EUR x N/A |
| Ask | 0.43 EUR x N/A |
| Day's Range | 0.35 - 0.35 EUR |
| 52 Week Range | 0.21 - 0.47 EUR |
| Volume | 800 EUR |
| Avg. Volume | 14 EUR |
| Market Cap | 28.32M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8I7.F Valuation Measures
| Enterprise Value | 23.38M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | -5203.5493 |
| Price/Book (mrq) | 21.749998 |
| Enterprise Value/Revenue | -4295.912 |
| Enterprise Value/EBITDA | -4.402 |
Trading Information
Gemina Laboratories Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 60.86% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.47 EUR |
| 52 Week Low | 0.21 EUR |
| 50-Day Moving Average | 0.38 EUR |
| 200-Day Moving Average | 0.34 EUR |
8I7.F Share Statistics
| Avg. Volume (3 month) | 14 EUR |
| Avg. Daily Volume (10-Days) | 80 EUR |
| Shares Outstanding | 73.33M |
| Float | 29.64M |
| Short Ratio | N/A |
| % Held by Insiders | 56.28% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | January 31, 2022 |
| Most Recent Quarter (mrq) | October 31, 2022 |
| Next Fiscal Year End | January 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 97918.00% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -147.65% |
| Return on Equity (ttm) | -346.70% |
Income Statement
| Revenue (ttm) | -5443 EUR |
| Revenue Per Share (ttm) | 0 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -5312257 EUR |
| Net Income Avi to Common (ttm) | -5330588 EUR |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 584.84K EUR |
| Total Cash Per Share (mrq) | 0.009 EUR |
| Total Debt (mrq) | 250.77K EUR |
| Total Debt/Equity (mrq) | 24.13 EUR |
| Current Ratio (mrq) | 2.434 |
| Book Value Per Share (mrq) | 0.016 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5416725 EUR |
| Levered Free Cash Flow (ttm) | -3558026 EUR |
Profile of Gemina Laboratories Ltd.
| Country | Germany |
| State | BC |
| City | Burnaby |
| Address | 3600 Gilmore Way |
| ZIP | V5G 4R9 |
| Phone | N/A |
| Website | https://www.geminalabs.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops and patented a transformative bio-chemistry that powers next-generation testing platforms for detecting a wide range of pathogens that affect humans and animals. It is developing platforms for the rapid testing of COVID-19, influenza, and other viruses. The company is headquartered in Burnaby, Canada.
Q&A For Gemina Laboratories Ltd. Stock
What is a current 8I7.F stock price?
Gemina Laboratories Ltd. 8I7.F stock price today per share is 0.29 EUR.
How to purchase Gemina Laboratories Ltd. stock?
You can buy 8I7.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gemina Laboratories Ltd.?
The stock symbol or ticker of Gemina Laboratories Ltd. is 8I7.F.
Which industry does the Gemina Laboratories Ltd. company belong to?
The Gemina Laboratories Ltd. industry is Biotechnology.
How many shares does Gemina Laboratories Ltd. have in circulation?
The max supply of Gemina Laboratories Ltd. shares is 77.54M.
What is Gemina Laboratories Ltd. Price to Earnings Ratio (PE Ratio)?
Gemina Laboratories Ltd. PE Ratio is now.
What was Gemina Laboratories Ltd. earnings per share over the trailing 12 months (TTM)?
Gemina Laboratories Ltd. EPS is -0.05 EUR over the trailing 12 months.
Which sector does the Gemina Laboratories Ltd. company belong to?
The Gemina Laboratories Ltd. sector is Healthcare.